The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Lowrie, Luke Henry
    Sales Director born in October 1984
    Individual (4 offsprings)
    Officer
    2021-02-17 ~ now
    OF - Director → CIF 0
    Mr Luke Henry Lowrie
    Born in October 1984
    Individual (4 offsprings)
    Person with significant control
    2021-02-22 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 2
    Lowrie, Emma
    Individual (1 offspring)
    Officer
    2021-05-31 ~ now
    OF - Secretary → CIF 0
    Mrs. Emma Lowrie
    Born in December 1982
    Individual (1 offspring)
    Person with significant control
    2024-04-24 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 4
  • 1
    Wallhead, Leah Violet
    Commercial Director born in July 1980
    Individual (1 offspring)
    Officer
    2019-12-18 ~ 2021-11-04
    OF - Director → CIF 0
    Ms Leah Violet Wallhead
    Born in July 1980
    Individual (1 offspring)
    Person with significant control
    2019-12-18 ~ 2021-02-22
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Edgington, Maurice John
    Individual (25 offsprings)
    Officer
    2019-12-18 ~ 2021-05-31
    OF - Secretary → CIF 0
  • 3
    EMERGING MEDICAL TECHNOLOGIES LTD
    Statue House, Aldgate High Street, London, England
    Active Corporate (1 parent)
    Equity (Company account)
    1 GBP2023-05-31
    Person with significant control
    2020-09-18 ~ 2021-09-14
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 4
    Flat 25, Pandorea House, 35 Lismore Boulevard, London, United Kingdom
    Dissolved Corporate (3 parents)
    Person with significant control
    2019-12-18 ~ 2020-06-30
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

GENETECH PHARMACEUTICALS LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Property, Plant & Equipment
15,789 GBP2024-03-31
17,277 GBP2023-03-31
Total Inventories
900,042 GBP2024-03-31
480,556 GBP2023-03-31
Debtors
1,049,719 GBP2024-03-31
366,488 GBP2023-03-31
Cash at bank and in hand
552,474 GBP2024-03-31
288,207 GBP2023-03-31
Current Assets
2,502,235 GBP2024-03-31
1,135,251 GBP2023-03-31
Creditors
Current
2,161,641 GBP2024-03-31
835,925 GBP2023-03-31
Net Current Assets/Liabilities
340,594 GBP2024-03-31
299,326 GBP2023-03-31
Total Assets Less Current Liabilities
356,383 GBP2024-03-31
316,603 GBP2023-03-31
Equity
Called up share capital
120 GBP2024-03-31
120 GBP2023-03-31
Retained earnings (accumulated losses)
356,263 GBP2024-03-31
316,483 GBP2023-03-31
Equity
356,383 GBP2024-03-31
316,603 GBP2023-03-31
Average Number of Employees
82023-04-01 ~ 2024-03-31
52022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
35,584 GBP2024-03-31
32,408 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
19,795 GBP2024-03-31
15,131 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
4,664 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
15,789 GBP2024-03-31
17,277 GBP2023-03-31
Trade Debtors/Trade Receivables
Amounts falling due within one year, Current
976,076 GBP2024-03-31
197,392 GBP2023-03-31
Other Debtors
Amounts falling due within one year, Current
64,278 GBP2024-03-31
159,731 GBP2023-03-31
Debtors
Amounts falling due within one year, Current
1,040,354 GBP2024-03-31
357,123 GBP2023-03-31
Other Debtors
Non-current, Amounts falling due after one year
9,365 GBP2024-03-31
9,365 GBP2023-03-31
Trade Creditors/Trade Payables
Current
1,649,411 GBP2024-03-31
718,785 GBP2023-03-31
Other Taxation & Social Security Payable
Current
46,131 GBP2024-03-31
50,838 GBP2023-03-31
Other Creditors
Current
225,079 GBP2024-03-31
13,369 GBP2023-03-31
  • GENETECH PHARMACEUTICALS LIMITED
    Info
    Registered number 12370221
    Unit 3 Enterprise Business Centre, Consul Avenue, Rainham RM13 8JE
    Private Limited Company incorporated on 2019-12-18 (5 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.